健康と病気における肺毛細血管ネットワークの輸送とバイオメカニクスのモデリング

Danielle Nemcovsky Amar¹, Anat Glozman¹, Josue Sznitman¹

¹Department of Biomedical Engineering, Technion - IIT, Haifa 32000, Israel.

Journal of biomechanical engineering

|September 1, 2025

まとめ

肺毛細血管ネットワーク (PCN) は,ガス交換に不可欠です. 微流体系を含む高度な生体模倣モデルは,PCNの機能と疾患の研究に革命を起こし,薬の開発を支援しています.

科学分野:

肺血管生物学
バイオミメティックモデリング
マイクロ流体

背景:

肺毛細血管ネットワーク (PCN) は,ガス交換と全身の恒常状態に不可欠です.
PCNの役割は酸素の輸送を超えて,健康や病気に関連する様々なプロセスに及ぶ.
科学的理解は解剖学的特徴から動的微循環研究へと進んだ.

研究の目的:

PCNの解剖学的および生理学的特性を検討する.
ホメオスタシスと病気におけるPCNの役割について議論する.
PCNのバイオメカニカルとインビトロモデルを検証する.

主な方法:

解剖学的および生理学的データのレビュー
血流のバイオメカニカルモデルの分析
微流体学に焦点を当てた in vitro バイオミメティックモデルの概要
次世代PCNモデルの議論

主要な成果:

PCNの複雑さとダイナミックな性質は,その機能に不可欠です.
実験室内モデル,特に微流体プラットフォームは,PCN生物学の研究においてますます重要になっています.
これらのモデルは,疾患モデリング,薬物投与研究,およびマイクロ血管機能の調査を容易にする.

結論:

バイオミメティックモデルは肺微血管生物学の研究を進めています
次世代のモデルはPCNの複雑さをより良く複製することを約束します
これらの高度なモデルは肺疾患の新たな治療戦略の開発を加速させるでしょう

さらに関連する動画

07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.4K

10:00

Author Spotlight: Advances in Quantifying Microvascular Density in Aging Murine Lungs

Published on: January 3, 2025

3.3K

関連する概念動画

00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

140

Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...

140

01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

108

Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...

108

01:30

Pulmonary Hypertension: Classification and Pathogenesis

284

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

284

01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

3.1K

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

3.1K

01:26

Pharmacokinetic Models: Comparison and Selection Criterion

147

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.

147

関連する実験動画